Published in Pharma Law Weekly, December 26th, 2006
The MCare 300 is a stand alone low acuity patient monitor as compared to the company's successful UltraviewSL patient monitor product line which is fully networked within the hospital's IT infrastructure.
The MCare 300 can be customized to meet the customers' specifications for patient parameters to be monitored. Standard configuration includes three and five lead electrocardiogram, respiration, SPO2, temperature and noninvasive blood pressure monitoring. The monitor utilizes the same touch screen interface as the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.